RX Recovery Program
The PBM Self-Funded Employer Recovery Initiative allows self-insured employers to recoup substantial funds from health plans.
​The DOJ has already established the guilt and liability of the drug companies and the pharmacy benefit management (PBM) companies. This is about recovery effort.
FILE TODAY!
There is no cost or expense to you.
Your Next Steps; easy as 1,2, 3
Step 1: Complete the NDA
To being, you will need to download and complete the Non-Disclosure Agreement. Then email back to the team at KA Global
Step 2: Email Completed NDA
Next, Email and attach completed NDA Agreement then return back to
KA Global. We will then prepare relevant documentation for your addition to these time sensitive MDL's
Step 3: Book An Appointment
Finally, you will need to book an appointment ASAP using the button below. This calendar is connected to our team of professionals who will assist you with final submission
About the MDL Litigation
Generic Pharmaceuticals Antitrust Pricing
Litigation
Multi-District Litigation Case # 2724
Evidence of these conspiracies has come to light in one of the most massive multidistrict civil antitrust cases in history, known as MDL2724, In re Generic Pharmaceuticals Pricing Antitrust Litigation. This litigation commenced in 2016 against dozens of pharmaceutical companies.
-
There is evidence of a common goal between competitors, consistent price increases and avoidance of price erosion, conduct to ensure fair market share allocation, and interdependence among competitors, and a plethora of communications that evince anticompetitive conduct.
​
-
There are also ongoing criminal cases against many of these companies and their former employees – with multiple indictments, various defendants pleading guilty to price fixing charges, deferred prosecution agreements being executed over one billion dollars being paid in fines, and dozens of individuals invoking the Fifth Amendment to avoid incriminating themselves further.
Price Fixing on Insulin Products
Multi-District Litigation Case # 3080
Since at least 2003, six large corporations have been able to
successfully exploit the U.S. healthcare system through a
conspiracy to intentionally hike insulin prices and line their
pockets through kickback schemes and agreements.
These companies include:
-
Three dominant insulin manufacturers – Eli Lilly, Novo, Nordisk, and Sanofi.
-
Three major PBMs – Express Scripts, CVS Caremark, and OptumRx.
-
These deliberate actions placed an economic burden on self-
-
funded health plans, impacting both their members and beneficiaries, while the manufacturers made billions, including:
-
Eli Lilly at $22.4B
-
Sanofi at $37B (2014-2018).
-
Frequently Asked Questions
Why are there drug recovery money for self-insured organizations?
Self-insured organizations have overpaid for drugs for several years due to pharmacy benefit management (PBM) and pharmaceutical company drug price fixing.
How long has this price fixing been ongoing?
The multi-district litigation (MDL) in question is from the year 2010 to the current time for the generic case and 2003 for the insulin case.
Is there proof that the PBMs and pharmaceutical companies are guilty?
The Department of Justice (DOJ) sued the PBMs and pharmaceutical companies and they have already admitted guilt. This litigation represents a money recovery effort. There is no need to prove guilt.
What are the estimated damages for an organization's overpayment of insulin and generic drugs?
Damages have been calculated to be over $100 million per 1,000 health plan members over the past 14 years. The actual amounts will be based on the amounts actually spent.
How do I know that my self-insured organization has been adversely affected by this drug price fixing?
A pharmaceutical data analytics company will take each self-insured organization’s drug claims data and calculate the monetary damages over a 14-year time frame to facilitate an accurate claim amount. It is common for over 80% of all drugs prescribed for a health plan population to be generic. All self-insured health plan organizations have been adversely affected.
Is there a deadline for filing? Is there an ERISA liability for not filing?
YES! January 14th, 2025, is a potential deadline under consideration by the Court. If the court sets this date as a cutoff, any organization not filed will be barred. Once the court sets a deadline, future claimants will have no opportunity for drug money recovery. A self-funded organization should also consider its ERISA fiduciary obligation. By not signing up, the ERISA liability of a self-insured organization is of great magnitude when the opportunity to recover money and save the health plan money is substantial